A Study of FZ-AD004 in Patients With Advanced Solid Tumors

Clinical trial NCT05914545 · RECRUITING

Trial details

NCT number: NCT05914545
Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced and Metastatic Solid Tumor

Start date: 2023-06-12
Primary completion: 2026-12-01
Enrollment: 121

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.